Promotions & Moves

IMS Health, Quintiles Name Key Officers for Merged Co.

Senior functional leaders will report to CEO following merger

By: Kristin Brooks

Managing Editor, Contract Pharma

IMS Health Holdings and Quintiles Transnational Holdings have appointed key senior management to the Quintiles IMS corporate leadership team, following completion of the merger.

Senior functional leaders reporting to chairman and chief executive officer Ari Bousbib will include Michael McDonnell, executive vice president and chief financial officer; James Erlinger, executive vice president and general counsel; and Trudy Stein, and executive vice president and chief human resources officer. Global business leaders reporting to Mr. Bousbib will include, Tom Pike, vice chairman and president, R&D Solutions for the clinical research business; Kevin Knightly, president, Information and Technology Solutions for the commercial business; José Luis Fernández, president, Global Services; Jon Resnick, president, Real-World Insights; and Scott Evangelista, president, Contract Sales Organization.

“I am proud to be part of a leadership team with deep industry knowledge, a proven track record of success and a commitment to transforming healthcare for the better,” said Ari Bousbib. “That commitment extends across the 50,000 talented professionals who will soon become part of one global team. Together, we are making excellent progress on our integration planning and are confident that we will be ready for a strong start on day one of the merger.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters